


Healthcare News Roundup: FDA
HSMN NewsFeed - 13 Sep 2007
FDA To Continue Its Review of Requests for Release of Clinical Hold on alvimopan (Entereg(R))
FDA To Continue Its Review of Requests for Release of Clinical Hold on alvimopan (Entereg(R))
HSMN NewsFeed - 12 Sep 2007
FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
HSMN NewsFeed - 12 Sep 2007
FDA Advisory Panel to Review Medtronic's Endeavor Drug Eluting Stent on October 10
FDA Advisory Panel to Review Medtronic's Endeavor Drug Eluting Stent on October 10
HSMN NewsFeed - 11 Sep 2007
Amgen to Review Benefits, Risks of ESA Therapy in Chronic Renal Failure Patients at FDA Advisory Committee
Amgen to Review Benefits, Risks of ESA Therapy in Chronic Renal Failure Patients at FDA Advisory Committee
HSMN NewsFeed - 10 Sep 2007
AGA Medical Corporation Receives Approval for the AMPLATZER Muscular Ventricular Septal Defect Occluder
AGA Medical Corporation Receives Approval for the AMPLATZER Muscular Ventricular Septal Defect Occluder
HSMN NewsFeed - 10 Sep 2007
Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery
Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery
HSMN NewsFeed - 10 Sep 2007
FDA Informs Endo and Vernalis That New Target Action Date on Frova(R) sNDA Is Sept. 30, 2007
FDA Informs Endo and Vernalis That New Target Action Date on Frova(R) sNDA Is Sept. 30, 2007
HSMN NewsFeed - 6 Sep 2007
Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
HSMN NewsFeed - 5 Sep 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
HSMN NewsFeed - 5 Sep 2007
Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
HSMN NewsFeed - 4 Sep 2007
GTC Obtains FDA Fast Track Designation for ATryn(R) and Permission to Submit a Rolling BLA
GTC Obtains FDA Fast Track Designation for ATryn(R) and Permission to Submit a Rolling BLA
HSMN NewsFeed - 31 Aug 2007
Ipsen: Somatuline(R) Depot Receives Marketing Approval in the United States for the Treatment of Acromegaly
Ipsen: Somatuline(R) Depot Receives Marketing Approval in the United States for the Treatment of Acromegaly
HSMN NewsFeed - 30 Aug 2007
Somatuline(R) Depot Receives FDA Marketing Approval for the Treatment of Acromegaly
Somatuline(R) Depot Receives FDA Marketing Approval for the Treatment of Acromegaly
HSMN NewsFeed - 30 Aug 2007
Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
HSMN NewsFeed - 30 Aug 2007
Abiomed Receives Conditional FDA Approval for Impella 2.5 Pivotal Study at up to 150 Hospitals
Abiomed Receives Conditional FDA Approval for Impella 2.5 Pivotal Study at up to 150 Hospitals
HSMN NewsFeed - 29 Aug 2007
FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
HSMN NewsFeed - 29 Aug 2007
Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
HSMN NewsFeed - 28 Aug 2007
FDA Accepts for Review Complete Response to Approvable Letter for Entereg(R) (alvimopan) for POI
FDA Accepts for Review Complete Response to Approvable Letter for Entereg(R) (alvimopan) for POI
HSMN NewsFeed - 28 Aug 2007
Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
HSMN NewsFeed - 27 Aug 2007
Medtronic Receives Approval for First Artificial Disc for the Neck in the U.S.
Medtronic Receives Approval for First Artificial Disc for the Neck in the U.S.
HSMN NewsFeed - 27 Aug 2007
IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
HSMN NewsFeed - 24 Aug 2007
AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
HSMN NewsFeed - 22 Aug 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
HSMN NewsFeed - 22 Aug 2007
U.S. FDA Approves GE Healthcare's Newest Mobile Mammography System for Improved Access to Breast Care
U.S. FDA Approves GE Healthcare's Newest Mobile Mammography System for Improved Access to Breast Care
HSMN NewsFeed - 21 Aug 2007
FDA Advisory Panel to Review Medtronic's Endeavor Drug Eluting Stent in October
FDA Advisory Panel to Review Medtronic's Endeavor Drug Eluting Stent in October
HSMN NewsFeed - 20 Aug 2007
Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
HSMN NewsFeed - 17 Aug 2007
Osmetech responds to U.S. Food and Drug Administration ('FDA') update labelling for warfarin
Osmetech responds to U.S. Food and Drug Administration ('FDA') update labelling for warfarin
HSMN NewsFeed - 17 Aug 2007
Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
HSMN NewsFeed - 16 Aug 2007
Pro-Pharmaceuticals Announces ''Compassionate Use'' IND for DAVANAT(R) to Treat Biliary Cancer Patient
Pro-Pharmaceuticals Announces ''Compassionate Use'' IND for DAVANAT(R) to Treat Biliary Cancer Patient
HSMN NewsFeed - 16 Aug 2007
Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
HSMN NewsFeed - 15 Aug 2007
Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
HSMN NewsFeed - 15 Aug 2007
Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel
Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel
HSMN NewsFeed - 14 Aug 2007
GlaxoSmithKline's Application for Rotarix(R) is Accepted for Review by the FDA
GlaxoSmithKline's Application for Rotarix(R) is Accepted for Review by the FDA
HSMN NewsFeed - 13 Aug 2007
Angiotech announces expansion of innovative Quill(TM) SRS product line with new choice of absorbable sutures
Angiotech announces expansion of innovative Quill(TM) SRS product line with new choice of absorbable sutures
HSMN NewsFeed - 10 Aug 2007
APP Receives Expedited Approval for the First and Only Generic Cefotetan Disodium for Injection
APP Receives Expedited Approval for the First and Only Generic Cefotetan Disodium for Injection
HSMN NewsFeed - 10 Aug 2007
Mylan Announces Final FDA Approval for Verapamil Hydrochloride Extended-Release Capsules (PM)
Mylan Announces Final FDA Approval for Verapamil Hydrochloride Extended-Release Capsules (PM)
HSMN NewsFeed - 10 Aug 2007
FDA Grants Additional Six Months Marketing Exclusivity for the High Blood Pressure Medicine Diovan(R)
FDA Grants Additional Six Months Marketing Exclusivity for the High Blood Pressure Medicine Diovan(R)
HSMN NewsFeed - 9 Aug 2007
GeneraMedix Inc. Announces FDA Approval and Launch of Ampicillin and Sulbactam for Injection, USP
GeneraMedix Inc. Announces FDA Approval and Launch of Ampicillin and Sulbactam for Injection, USP
HSMN NewsFeed - 8 Aug 2007
Syneron's Vela(TM) Platform Receives FDA Clearance for Temporary Reduction of Thigh Circumference
Syneron's Vela(TM) Platform Receives FDA Clearance for Temporary Reduction of Thigh Circumference
HSMN NewsFeed - 8 Aug 2007
Rilonacept (IL-1 Trap) Granted FDA Priority Review for the Treatment of CAPS
Rilonacept (IL-1 Trap) Granted FDA Priority Review for the Treatment of CAPS
HSMN NewsFeed - 7 Aug 2007
Lux Granted Fast Track Designation by FDA for LX211 for the Treatment of Uveitis
Lux Granted Fast Track Designation by FDA for LX211 for the Treatment of Uveitis
HSMN NewsFeed - 7 Aug 2007
Abraxis BioScience Receives FDA Approval for Oxytocin Injection 10 USP Units/mL in a 30 mL Vial
Abraxis BioScience Receives FDA Approval for Oxytocin Injection 10 USP Units/mL in a 30 mL Vial
HSMN NewsFeed - 6 Aug 2007
Encysive Pharmaceuticals Files Request for Formal Dispute Resolution With U.S. FDA
Encysive Pharmaceuticals Files Request for Formal Dispute Resolution With U.S. FDA
HSMN NewsFeed - 6 Aug 2007
Abraxis BioScience Receives Final Approval for Fosphenytoin Sodium Injection, USP
Abraxis BioScience Receives Final Approval for Fosphenytoin Sodium Injection, USP
HSMN NewsFeed - 6 Aug 2007
Pfizer's SelzentryTM (Maraviroc) Tablets, Novel Treatment for HIV, Approved by FDA
Pfizer's SelzentryTM (Maraviroc) Tablets, Novel Treatment for HIV, Approved by FDA
HSMN NewsFeed - 2 Aug 2007
Teva Announces Approval of Generic Protonix(R) Delayed Release Tablets, 20 mg and 40 mg
Teva Announces Approval of Generic Protonix(R) Delayed Release Tablets, 20 mg and 40 mg
HSMN NewsFeed - 1 Aug 2007
Genta and Emisphere Technologies File IND with FDA for Oral Drug to Treat Bone Disease
Genta and Emisphere Technologies File IND with FDA for Oral Drug to Treat Bone Disease
HSMN NewsFeed - 31 Jul 2007
Lev Pharmaceuticals Submits Biologics License Application for Cinryze(TM)
Lev Pharmaceuticals Submits Biologics License Application for Cinryze(TM)
HSMN NewsFeed - 31 Jul 2007
BSD Medical Files Response to FDA Questions on BSD-2000 PMA Submission Following Meeting with FDA
BSD Medical Files Response to FDA Questions on BSD-2000 PMA Submission Following Meeting with FDA
HSMN NewsFeed - 31 Jul 2007
FDA Advisory Panel Votes 22 to 1 for Avandia(R) to Remain Available to Patients in the US
FDA Advisory Panel Votes 22 to 1 for Avandia(R) to Remain Available to Patients in the US
HSMN NewsFeed - 30 Jul 2007
KV Pharmaceutical Announces U.S. Food and Drug Administration Approval of EvaMist(TM)
KV Pharmaceutical Announces U.S. Food and Drug Administration Approval of EvaMist(TM)
HSMN NewsFeed - 27 Jul 2007
Akorn, Inc. Announces FDA Approval of Ketotifen Fumarate Ophthalmic Solution, 0.025%
Akorn, Inc. Announces FDA Approval of Ketotifen Fumarate Ophthalmic Solution, 0.025%
HSMN NewsFeed - 26 Jul 2007
St. Jude Medical Receives FDA Clearance for ACross Transseptal Access System
St. Jude Medical Receives FDA Clearance for ACross Transseptal Access System
HSMN NewsFeed - 25 Jul 2007
FDA Classifies Baxter's Voluntary Recall Action Regarding Service Documentation as a Class I Recall
FDA Classifies Baxter's Voluntary Recall Action Regarding Service Documentation as a Class I Recall
HSMN NewsFeed - 25 Jul 2007
Lutronic USA LLC Earns US FDA Clearance for MOSAIC Fractional Laser System
Lutronic USA LLC Earns US FDA Clearance for MOSAIC Fractional Laser System
HSMN NewsFeed - 25 Jul 2007
FDA Approves Conceptus' Third Generation Essure(R) Permanent Birth Control System
FDA Approves Conceptus' Third Generation Essure(R) Permanent Birth Control System
HSMN NewsFeed - 25 Jul 2007
FDA Accepts Innovative Drug Application - ImmunoMod Begins Diabetes Therapeutic Trials
FDA Accepts Innovative Drug Application - ImmunoMod Begins Diabetes Therapeutic Trials
HSMN NewsFeed - 25 Jul 2007
St. Jude Medical Announces FDA Clearance of the Proxis Embolic Protection System
St. Jude Medical Announces FDA Clearance of the Proxis Embolic Protection System
HSMN NewsFeed - 25 Jul 2007
Antares Reaches Agreement with FDA on Special Protocol Assessment for Pivotal Trial of Anturol(TM)
Antares Reaches Agreement with FDA on Special Protocol Assessment for Pivotal Trial of Anturol(TM)
HSMN NewsFeed - 24 Jul 2007
Icagen Announces Filing of IND for ICA-105665, a Novel Compound for the Treatment of Epilepsy
Icagen Announces Filing of IND for ICA-105665, a Novel Compound for the Treatment of Epilepsy
HSMN NewsFeed - 24 Jul 2007
Neurochem granted Fast Track designation from U.S. FDA for tramiprosate (ALZHEMED(TM))
Neurochem granted Fast Track designation from U.S. FDA for tramiprosate (ALZHEMED(TM))
HSMN NewsFeed - 20 Jul 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Provigil(R)
Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Provigil(R)
HSMN NewsFeed - 20 Jul 2007
CMS, Inc. Applies for 510(k) for Monaco(TM), The Next Generation in IMRT Planning
CMS, Inc. Applies for 510(k) for Monaco(TM), The Next Generation in IMRT Planning
